Rivoglitazone - a thiazolidinedione derivative which is an agonist of the protein receptor PPARgamma found in fat tissue. Activation of PPARgamma lowers blood sugar by increasing sensitivity to insulin and changing the metabolism of fat and sugar. It can potentially be used for the treatment of type-2 diabetes.












